Pharmaceuticals, Biotechnology and Life Sciences
WALTHAM, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology…
Company Announcement Genmab improves its 2021 financial guidance COPENHAGEN, Denmark; November 4, 2021 – Genmab A/S (Nasdaq: GMAB) announced today…
Third Quarter Net Revenue of $2.6 MillionUp 24% Year-Over-Year and 16% Quarter-over-Quarter SOUTH ORANGE, NJ, Nov. 04, 2021 (GLOBE NEWSWIRE)…
-Initial data release from Phase 2 study of CX-2029 remains on track for fourth quarter 2021- -Initial data release from…
BOSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (NASDAQ: APRE), a biopharmaceutical company focused on developing and commercializing…
Successfully completed multiple ascending dose (MAD) portion of a Phase 1 clinical trial for LP352, a potential treatment for seizures…
CAMBRIDGE, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…
Company to host an investor conference call and webcast at 5:00pm ET on that dayNEW YORK, Nov. 04, 2021 (GLOBE…
– Entered into additional licensing agreement with The University of Texas MD Anderson Cancer Center for use of CaspaCIDe® safety…
Leading global genomics and diagnostic testing firm adds more comprehensive genetic information to its services.MENLO PARK, Calif. and HONG KONG,…